A procedure for producing an anti-AXL nanobody in E. coli
Zhongyun Lan, Lingyun Li, Yili Sun, Xiangjing Meng, Zhenzhong Shi, Mengyang Du, Hui Wang, Zengchao Sun, Qianqian Cui, Lu Wang, Tengjie Geng, Siyu Zhou, Yi'ang Wang, Fangzheng Hu, Chonggang Duan, Yong
Journal:PROTEIN EXPRESSION AND PURIFICATION
IF:1.6
DOI:10.1016/j.pep.2023.106268
PMID:37023993
Published:2023-04-04
research field:分子生物学癌症研究免疫学生物技术
Abstract
As one of the receptors of the TAM family, AXL plays a vital role in stem cell maintenance, angiogenesis , immune escape of viruses and drug resistance against tumors. In this study, the truncated extracellular segment containing two immunoglobulin-like domains of human AXL (AXL-IG), which has been confirmed to bind growth arrest specific 6 (GAS6) by structural studies [1], was expressed in a prokaryotic expression system and then purified. Immunizing camelid with the purified AXL-IG as antigen could lead to the production of unique nanobodies composed of only variable domain of heavy chain of heavy-chain antibody (VHH), which are around 15 kD and stable. We screened out a nanobody A-LY01 specific binding to AXL-IG. We further determined the affinity of A-LY01 to AXL-IG and revealed that A-LY01 could specifically recognize full-length AXL on the surface of HEK 293T/17 cells. Our study provides appropriate support for the development of diagnostic reagents and antibody therapeutics targeting AXL.
本文使用的Yeasen产品


